午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

TargetMol Chemicals Inc.??? ?? ??? ?????.

?? ?:TargetMol Chemicals Inc.
??:-
???:marketing@targetmol.cn
??:China
URL: https://www.targetmol.cn/
? ?? ?:26070

?? ????

A-9335481037826-43-9C25H21N5O3
A1B111602731-56-5C22H25N5O
Tecovirimat hydrate1162664-19-8C19H17F3N2O4
AY 9944 dihydrochloride1-(2-?????)-N-[[4-[(2-?????)???????]??????]??]????????1245-84-7C22H28Cl2N2
Aceratioside????????133084-09-0C17H22O9
20681-S73361-71-4C21H29NO5S
PF-067950712075629-81-9C18H17F4N3O3
Oral antiplatelet agent 12299200-91-0C23H24N4O5S
GLPG-32212222264-64-2C30H37F3N2O6
AD-2646366487-89-0C23H40N2O4
ACT-4518401839508-99-4C47H54N6O3
ACJI-99C1135195-64-0C18H19N5O
Adapiprazine57942-72-0C29H36ClN3S
Semax acetate(80714-61-0 free base)2828433-33-4C37H51N9O10S.C2H4O2
Lesopitron HCl132449-88-8C15H21ClN6.ClH
Levomecol????118573-58-3C16H18Cl2N4O7
UB 165 fumarate2454492-43-2C13H15ClN2.C4H4O4
LBW242867324-12-7C27H42N4O2
PPTN1160271-30-6C29H24F3NO2
Phortress free base741241-36-1C20H23FN4OS
QPX7728 bis-acetoxy methyl ester2170834-56-5C15H14BFO8
(S)-BI 6659151360550-05-5C24H26N8O2
Ab42-IN-C2439932-74-8C15H16Cl2N2O2S2
Atiratecan867063-97-6C31H34N6O6
Glycosidase-IN-2476310-39-1C13H23NO5
OMDM-3616884-64-1C29H43NO3
OSMI-32260791-13-5C32H35N3O9S2
VDR agonist 12269494-43-9C32H51N3O2
Isoproterenol bitartrate59-60-9C11H17NO3.C4H6O6
A-4242741335145-56-6C14H15N3
Acodazole hydrochloride55435-65-9C20H20ClN5O
Acodazole79152-85-5
Oxaquin790704-50-6C31H33F2N4O11P
PDE1-IN-32370966-46-2C18H24N4O
IDO1-IN-22346614-58-0C15H17FN6O4
NR1H4 activator 12242855-68-9C34H53NO7S
PDE5-IN-22244517-61-9C25H21N3O6S
5-Hydroxylansoprazole sulfone131927-00-9C16H14F3N3O4S
Acetobixan380201-24-1C16H17NO2S
JBJ-02-112-052748162-29-8C27H20N4O2S
Bocconoline1322007-90-8C22H21NO5
Turbinaric acid???56882-00-9C27H44O2
7-Deoxyloganic acid22487-36-1C16H24O9
Fobrepodacin disodium1384984-20-6C21H27FN6NaO6P
AN112512130750-59-1C29H38BFO7
MCL-1/BCL-2-IN-42163793-56-2C26H23BrN2O5S
BIZ 1142099120-74-6C24H40O3
RORγt Inverse agonist 21801197-92-1C27H25F8NO5S
Syk-IN-31312534-69-2C24H28N4O3S
Tyk2-IN-92127109-85-5C20H17N9
Murizatoclax2245848-05-7C42H57ClN4O5S
SLLN-152403650-93-9C19H23N7Se2
(Rac)-PF-062501121609465-88-4C22H20F2N6O2
(S)-Gyramide A1000592-48-2C21H27FN2O3S
A-9408941027330-82-0C17H21N5
ADD-1701455643-87-3C13H11ClN4
Atopaxar hydrochloride474544-83-7C29H39ClFN3O5
Integrin-IN-22378617-67-3C27H30N4O3
OMDM-4616884-65-2C29H43NO3
PKR activator 12283420-62-0C16H14N8OS2
RORγt agonist 12377378-89-5C24H17F6NO5S
TP3011534605-74-8C26H26N4O5
Ppc-11245818-17-0C21H25NO4
A4571233923-95-9C26H33ClN2O3
ACEA1011153504-72-4C9H4ClF3N2O2
Mebeverine alcohol D52070015-15-3C16H27NO2
Pulrodemstat Methylbenzenesulfonate2097523-57-2C31H31F2N5O5S
PDE9-IN-12305087-92-5C17H23FN6O2
BN2011361200-34-1C25H38FN5O4
(+)-SHIN12443966-90-1C24H24N4O2
TLC3407-3786896356-25-5C19H19N3O4
58-G3287174-44-1C14H12Cl2N4O5
A2B571602733-73-2C22H19N5O
Alvameline maleate219581-36-9C13H19N5O4
PARP-2-IN-12115698-83-2C21H19F4N5O3
Glucagon receptor antagonists-52200274-63-9C30H29ClF3N3O3
(+/-)-Terreic acid15255-24-0C7H6O4
Asteltoxin79663-49-3C23H30O7
Adatanserin127266-56-2C21H31N5O
TT-232 TFA(147159-51-1 free base)2703745-48-4C45H58N10O9S2.C2HF3O2
Acorafloxacin HCl1001162-01-1C21H24ClF2N3O4
(R)-OR-S11809336-19-3C26H34BrN3O4
JAK-IN-41400877-37-3C18H22N4NaO6P
GPR40 agonist 11853982-41-8C27H30FN3O4
BMS-9861631801151-09-6C23H28FN2O5P
HCV-IN-71449756-86-8C40H48N8O6S
PKR activator 22283422-04-6C18H16N8OS
Py-MPB-amino-C3-PBD2412924-07-1C41H44N8O6
A-9532271037826-77-9C25H20FN5O3
Isoxsuprine-monoester-167160-74-1C23H31NO4
JMV 2959 hydrochloride (925238-89-7 free base)2448414-54-6C30H33ClN6O2
AD 20??20?111542-07-5C12H13NO4
Methyl 3-[2-[[(4R)-4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl]methylamino]ethyl]benzoate2725484-87-5C27H36N2O4
13-Hydroxystevane???-13-?5749-44-0C20H34O
TP-0041454299-21-8C17H16F3N5O
Glycosidase-IN-1170376-12-2C13H23NO5
OSMI-22260542-60-5C26H25N3O7S2
RIP2 kinase inhibitor 12380028-10-2C17H17N5O2S
VBIT-32088463-66-3C21H19ClF3N3O3
Acrisorcin7527-91-5C13H10N2.C12H18O2
Copyright 2019 ? ChemicalBook. All rights reserved